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Julian Amirault1, Yufeng Wang1, Logan Riegel1, Xueyin He1, Tan Shi Rui1, Michael Valic1, Praveen K. Vemula1,2,3,6,
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Correction to: Nature Communications https://doi.org/10.1038/s41467-018-03691-1, published online 03 April 2018.
In the original version of this Article, ﬁnancial support was not fully acknowledged. The PDF and HTML versions of the Article have
now been corrected to include support from the National Football League Players Association.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
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